Similar to Tregs, these TNFR2-expressing cell types may exhibit a negative feedback mechanism to suppress the pathological effects of excessive TNF–TNFR1 signaling, e.g. in neurological disorders (37). This evidence concerns the gene TNFRSF1A and nervous system disorder.